Abstract
Atrial fibrillation (AF) is by far the most common arrhythmia. It occurs more often with increasing age. Patients with AF almost always require oral anticoagulants and a rate-control treatment. In addition, other cardiovascular diseases must also be carefully treated in order to reduce the risks of cardiovascular complications from AF. Most patients profit from rate-control treatment with drugs that slow the conduction of the electrical impulse through the AV node. The aim is a resting heart rate of 100-110/min. If patients suffer from AF whilst on optimal rate control therapy, rhythm-control treatment with antiarrhythmic drugs, cardioversion or catheter ablation is indicated. The choice of the rhythm-control therapy should be made based on safety considerations. Whether achieving sinus rhythm beyond improvement of symptoms improves the prognosis of AF is tested in ongoing trials.
| Translated title of the contribution | Atrial fibrillation: current recommendations for diagnosis and treatment |
|---|---|
| Original language | German |
| Pages (from-to) | 583-95 |
| Number of pages | 13 |
| Journal | Der Internist |
| Volume | 54 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-Arrhythmia Agents
- Atrial Fibrillation
- Catheter Ablation
- Electric Countershock
- Electrocardiography
- Humans
- Practice Guidelines as Topic
Fingerprint
Dive into the research topics of 'Atrial fibrillation: current recommendations for diagnosis and treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver